The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
SYLVANT siltuximab (rmc) 100mg powder for injection vial (229996)
ARTG Name
SYLVANT siltuximab (rmc) 100mg powder for injection vial
Product name
SYLVANT siltuximab (rmc) 100mg powder for injection vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Ingredients
siltuximab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information